A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation
about
Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose.Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation.Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT.Improving engraftment and immune reconstitution in umbilical cord blood transplantation.New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity.
P2860
A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A phase I/II study of chemothe ...... topoietic cell transplantation
@ast
A phase I/II study of chemothe ...... topoietic cell transplantation
@en
type
label
A phase I/II study of chemothe ...... topoietic cell transplantation
@ast
A phase I/II study of chemothe ...... topoietic cell transplantation
@en
prefLabel
A phase I/II study of chemothe ...... topoietic cell transplantation
@ast
A phase I/II study of chemothe ...... topoietic cell transplantation
@en
P2093
P2860
P50
P1476
A phase I/II study of chemothe ...... topoietic cell transplantation
@en
P2093
Alexander Fefer
Edus H Warren
Jean E Sanders
Mary E D Flowers
Paul J Martin
Theodore A Gooley
Yoshihiro Inamoto
P2860
P304
P356
10.1016/J.BBMT.2011.01.004
P577
2011-01-11T00:00:00Z